FDA Advisory Panel Narrowly Votes Against New ALS Drug

THURSDAY, March 31, 2022 -- In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for the deadly neurological disease amyotrophic lateral sclerosis (ALS).

The...